Free shipping on all orders over $ 500

Nimorazole

Cat. No. M3944

All AbMole products are for research use only, cannot be used for human consumption.

Nimorazole Structure
Synonym:

K-1900

Size Price Availability Quantity
10mM*1mL in DMSO USD 55 In stock
5mg USD 30 In stock
10mg USD 50 In stock
50mg USD 90 In stock
100mg USD 130 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Nimorazole is the only such agent to have shown a significant effect in a randomized controlled trial in head and neck cancer. Comparison with a historical group of patients,treated with the CHART regimen alone and matched for irradiation volume and technique, showed that nimorazole did not increase the severity of acute normal tissue radiation effects. Encouraging tumor responses have been seen in the patients receiving nimorazole with every radiotherapy fraction.Nimorazole significantly improves the effect of radiotherapeutic management of supraglottic and pharynx tumors and can be given without major side-effects.

Chemical Information
Molecular Weight 226.23
Formula C9H14N4O3
CAS Number 6506-37-2
Solubility (25°C) DMSO ≥ 70 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Henk JM, et al. Radiother Oncol. Treatment of head and neck cancer with CHART and nimorazole: phase II study.

[2] Cottrill CP, et al. Int J Radiat Oncol Biol Phys. Pilot study of nimorazole as a hypoxic-cell sensitizer with the "chart" regimen in head and neck cancer.

[3] Overgaard J, et al. Radiother Oncol. A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85.

Related Anti-infection Products
PSI-6206

PSI-6206 is the deaminated derivative of PSI-6130, which is a potent and selective inhibitor of HCV NS5B polymerase. PSI-6206 low potently inhibits HCV replicon with EC90 of >100 μM.

BTZ043 Racemate

BTZ043 Racemate (BTZ038, BTZ044) is a decaprenylphosphoryl-b-D-ribose 2-epimerase inhibitor.

Enoxacin

Enoxacin is a small molecule inhibitor of binding between the B2-subunit of vacuolar H+-ATPase (V-ATPase) and microfilaments.

Posaconazole

Posaconazole is a sterol C14α demethylase inhibitor with IC50 of 0.25 nM.

Pretomanid

Pretomanid (PA-824) is a novel, orally active nitroimidazole derivative with antimycobacterial activity for use in tuberculosis-related studies.

  Catalog
Abmole Inhibitor Catalog




Keywords: Nimorazole, K-1900 supplier, Anti-infection, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.